✦ LIBER ✦

Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer

✍ Scribed by Hanan A. Wahba; Amal A. Halim; Hend A. El-Hadaad

Book ID: 107577385
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 211 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9772-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalation study of thoraci

Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group RTOG

✍ R Komaki; S Swann; D Ettinger; B Glisson; A Sandler; B Movsas; R Byhardt 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 19 KB

Induction chemotherapy employing dose-in

Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma

✍ Kenneth K. Ng; Mark G. Kris; Robert J. Ginsberg; Robert T. Heelan; Katherine M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. Cisplatin-based induction chemotherapy before surgery or irradiation has improved the survival of patients with Stage III nonsmall cell lung carcinoma (NSCLC). Encouraged by earlier results with preoperative MVP (cisplatin [120 mg/m 2 or 25 mg/m 2 /week], vinblastine, and mitomycin)